{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T02:29:33Z","timestamp":1773887373130,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T00:00:00Z","timestamp":1575590400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T00:00:00Z","timestamp":1575590400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81770568"],"award-info":[{"award-number":["81770568"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University","award":["ZYJC18008"],"award-info":[{"award-number":["ZYJC18008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s10067-019-04853-2","type":"journal-article","created":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T04:53:35Z","timestamp":1575608015000},"page":"795-803","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Concomitant systemic lupus erythematosus might have a negative impact on the biochemical responses to treatment in patients with primary biliary cholangitis"],"prefix":"10.1007","volume":"39","author":[{"given":"Xiaoli","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruoting","family":"Men","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changli","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tengfei","family":"Si","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3821-9342","authenticated-orcid":false,"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,6]]},"reference":[{"key":"4853_CR1","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","volume":"386","author":"EJ Carey","year":"2015","unstructured":"Carey EJ, Ali AH, Lindor KD (2015) Primary biliary cirrhosis. Lancet. 386:1565\u20131575","journal-title":"Lancet."},{"key":"4853_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","volume":"67","author":"GM Hirschfield","year":"2017","unstructured":"Hirschfield GM, Beuers U, Corpechot C et al (2017) EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J Hepatol 67:145\u2013172","journal-title":"J Hepatol"},{"key":"4853_CR3","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.3748\/wjg.v19.i31.5131","volume":"19","author":"L Wang","year":"2013","unstructured":"Wang L, Zhang FC, Chen H, Zhang X, Xu D, Li YZ, Wang Q, Gao LX, Yang YJ, Kong F, Wang K (2013) Connective tissue diseases in primary biliary cirrhosis: a population-based cohort study. World J Gastroenterol 19:5131\u20135137","journal-title":"World J Gastroenterol"},{"key":"4853_CR4","doi-asserted-by":"publisher","first-page":"7396870","DOI":"10.1155\/2019\/7396870","volume":"2019","author":"P Ni","year":"2019","unstructured":"Ni P, Men R, Shen M et al (2019) Concomitant Sjogren\u2019s syndrome was not associated with a poorer response or outcomes in ursodeoxycholic acid-treated patients with primary biliary cholangitis. Can J Gastroenterol Hepatol 2019:7396870","journal-title":"Can J Gastroenterol Hepatol"},{"key":"4853_CR5","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0140-6736(07)60279-7","volume":"369","author":"DP D\u2019Cruz","year":"2007","unstructured":"D\u2019Cruz DP, Khamashta MA, Hughes GR (2007) Systemic lupus erythematosus. Lancet. 369:587\u2013596","journal-title":"Lancet."},{"key":"4853_CR6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00281-014-0428-6","volume":"36","author":"OP Rekvig","year":"2014","unstructured":"Rekvig OP, Van der Vlag J (2014) The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved. Semin Immunopathol 36:301\u2013311","journal-title":"Semin Immunopathol"},{"key":"4853_CR7","doi-asserted-by":"publisher","first-page":"713728","DOI":"10.1155\/2015\/713728","volume":"2015","author":"T Shizuma","year":"2015","unstructured":"Shizuma T (2015) Clinical characteristics of concomitant systemic lupus erythematosus and primary biliary cirrhosis: a literature review. J Immunol Res 2015:713728","journal-title":"J Immunol Res"},{"key":"4853_CR8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jaut.2012.12.003","volume":"41","author":"MS Longhi","year":"2013","unstructured":"Longhi MS, Ma Y, Grant CR, Samyn M, Gordon P, Mieli-Vergani G, Vergani D (2013) T-regs in autoimmune hepatitis-systemic lupus erythematosus\/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile. J Autoimmun 41:146\u2013151","journal-title":"J Autoimmun"},{"key":"4853_CR9","doi-asserted-by":"publisher","first-page":"6560","DOI":"10.1038\/s41598-017-06807-7","volume":"7","author":"X Fan","year":"2017","unstructured":"Fan X, Wang T, Shen Y et al (2017) Underestimated male prevalence of primary biliary cholangitis in China: results of a 16-yr cohort study involving 769 patients. Sci Rep 7:6560","journal-title":"Sci Rep"},{"key":"4853_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/hep.22906","volume":"50","author":"KD Lindor","year":"2009","unstructured":"Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ, American Association for Study of Liver Diseases (2009) Primary biliary cirrhosis. Hepatology. 50:291\u2013308","journal-title":"Hepatology."},{"key":"4853_CR11","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725","journal-title":"Arthritis Rheum"},{"key":"4853_CR12","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/MEG.0000000000000637","volume":"28","author":"S Olmez","year":"2016","unstructured":"Olmez S, Sayar S, Avcioglu U, Tenlik \u0130, Ozaslan E, Koseoglu HT, Altiparmak E (2016) The relationship between liver histology and noninvasive markers in primary biliary cirrhosis. Eur J Gastroenterol Hepatol 28:773\u2013776","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"4853_CR13","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jhep.2014.01.029","volume":"60","author":"PJ Trivedi","year":"2014","unstructured":"Trivedi PJ, Bruns T, Cheung A, Li KK, Kittler C, Kumagi T, Shah H, Corbett C, al-Harthy N, Acarsu U, Coltescu C, Tripathi D, Stallmach A, Neuberger J, Janssen HL, Hirschfield GM (2014) Optimising risk stratification in primary biliary cirrhosis: AST\/platelet ratio index predicts outcome independent of ursodeoxycholic acid response. J Hepatol 60:1249\u20131258","journal-title":"J Hepatol"},{"key":"4853_CR14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res 46:399\u2013424","journal-title":"Multivar Behav Res"},{"key":"4853_CR15","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S1665-2681(19)30838-5","volume":"13","author":"WJ Lammers","year":"2014","unstructured":"Lammers WJ, Kowdley KV, van Buuren HR (2014) Predicting outcome in primary biliary cirrhosis. Ann Hepatol 13:316\u2013326","journal-title":"Ann Hepatol"},{"key":"4853_CR16","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s12016-014-8427-x","volume":"48","author":"A Floreani","year":"2015","unstructured":"Floreani A, Franceschet I, Cazzagon N, Spinazz\u00e8 A, Buja A, Furlan P, Baldo V, Gershwin ME (2015) Extrahepatic autoimmune conditions associated with primary biliary cirrhosis. Clin Rev Allergy Immunol 48:192\u2013197","journal-title":"Clin Rev Allergy Immunol"},{"key":"4853_CR17","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.3748\/wjg.v19.i7.1111","volume":"19","author":"TY Shi","year":"2013","unstructured":"Shi TY, Zhang LN, Chen H, Wang L, Shen M, Zhang X, Zhang FC (2013) Risk factors for hepatic decompensation in patients with primary biliary cirrhosis. World J Gastroenterol 19:1111\u20131118","journal-title":"World J Gastroenterol"},{"key":"4853_CR18","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/apt.13448","volume":"43","author":"KA Kim","year":"2016","unstructured":"Kim KA, Ki M, Choi HY, Kim BH, Jang ES, Jeong SH (2016) Population-based epidemiology of primary biliary cirrhosis in South Korea. Aliment Pharmacol Ther 43:154\u2013162","journal-title":"Aliment Pharmacol Ther"},{"key":"4853_CR19","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1002\/eji.201344270","volume":"44","author":"M Carbone","year":"2014","unstructured":"Carbone M, Lleo A, Sandford RN et al (2014) Implications of genome-wide association studies in novel therapeutics in primary biliary cirrhosis. Eur J Immunol 44:945\u2013954","journal-title":"Eur J Immunol"},{"key":"4853_CR20","first-page":"504","volume":"28","author":"M Piga","year":"2010","unstructured":"Piga M, Vacca A, Porru G, Cauli A, Mathieu A (2010) Liver involvement in systemic lupus erythematosus: incidence, clinical course and outcome of lupus hepatitis. Clin Exp Rheumatol 28:504\u2013510","journal-title":"Clin Exp Rheumatol"},{"key":"4853_CR21","first-page":"36","volume":"7","author":"L Wang","year":"2013","unstructured":"Wang L, Yang Y, Zhang X et al (2013) Clinical features of primary biliary cirrhosis and systemic lupus erythematosus. Chin J Allergy Clin Immunol 7:36\u201340","journal-title":"Chin J Allergy Clin Immunol"},{"key":"4853_CR22","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1053\/berh.2002.0259","volume":"16","author":"M Petri","year":"2002","unstructured":"Petri M (2002) Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 16:847\u2013858","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"4853_CR23","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1177\/0961203312458168","volume":"21","author":"K Lerang","year":"2012","unstructured":"Lerang K, Gilboe I, Garen T, Thelle DS, Gran JT (2012) High incidence and prevalence of systemic lupus erythematosus in Norway. Lupus. 21:1362\u20131369","journal-title":"Lupus."},{"key":"4853_CR24","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1191\/0961203306lu2305xx","volume":"15","author":"N Danchenko","year":"2006","unstructured":"Danchenko N, Satia JA, Anthony MS (2006) Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus. 15:308\u2013318","journal-title":"Lupus."},{"key":"4853_CR25","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1177\/0961203310374305","volume":"19","author":"E Osio-Salido","year":"2010","unstructured":"Osio-Salido E, Manapat-Reyes H (2010) Epidemiology of systemic lupus erythematosus in Asia. Lupus. 19:1365\u20131373","journal-title":"Lupus."},{"key":"4853_CR26","first-page":"1978","volume":"35","author":"CC Mok","year":"2008","unstructured":"Mok CC, To CH, Ho LY et al (2008) Incidence and mortality of systemic lupus erythematosus in a southern Chinese population, 2000-2006. J Rheumatol 35:1978\u20131982","journal-title":"J Rheumatol"},{"key":"4853_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cld.2018.12.007","volume":"23","author":"A Gebreselassie","year":"2019","unstructured":"Gebreselassie A, Aduli F, Howell CD (2019) Rheumatologic diseases and the liver. Clin Liver Dis 23:247\u2013261","journal-title":"Clin Liver Dis"},{"key":"4853_CR28","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/0300-2977(96)00003-4","volume":"48","author":"B van Hoek","year":"1996","unstructured":"van Hoek B (1996) The spectrum of liver disease in systemic lupus erythematosus. Neth J Med 48:244\u2013253","journal-title":"Neth J Med"},{"key":"4853_CR29","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3109\/00365521.2011.558114","volume":"46","author":"C Efe","year":"2011","unstructured":"Efe C, Purnak T, Ozaslan E et al (2011) Autoimmune liver disease in patients with systemic lupus erythematosus: a retrospective analysis of 147 cases. Scand J Gastroenterol 46:732\u2013737","journal-title":"Scand J Gastroenterol"},{"key":"4853_CR30","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.3899\/jrheum.080336","volume":"35","author":"VR Chowdhary","year":"2008","unstructured":"Chowdhary VR, Crowson CS, Poterucha JJ, Moder KG (2008) Liver involvement in systemic lupus erythematosus: case review of 40 patients. J Rheumatol 35:2159\u20132164","journal-title":"J Rheumatol"},{"key":"4853_CR31","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1111\/j.1872-034X.2010.00707.x","volume":"40","author":"A Takahashi","year":"2010","unstructured":"Takahashi A, Abe K, Yokokawa J, Iwadate H, Kobayashi H, Watanabe H, Irisawa A, Ohira H (2010) Clinical features of liver dysfunction in collagen diseases. Hepatol Res 40:1092\u20131097","journal-title":"Hepatol Res"},{"key":"4853_CR32","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.2169\/internalmedicine.52.9458","volume":"52","author":"A Takahashi","year":"2013","unstructured":"Takahashi A, Abe K, Saito R, Iwadate H, Okai K, Katsushima F, Monoe K, Kanno Y, Saito H, Kobayashi H, Watanabe H, Ohira H (2013) Liver dysfunction in patients with systemic lupus erythematosus. Intern Med 52:1461\u20131465","journal-title":"Intern Med"},{"key":"4853_CR33","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","volume":"130","author":"A Pares","year":"2006","unstructured":"Pares A, Caballeria L, Rodes J (2006) Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid. Gastroenterology. 130:715\u2013720","journal-title":"Gastroenterology."},{"key":"4853_CR34","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1038\/ajg.2010.216","volume":"105","author":"T Kumagi","year":"2010","unstructured":"Kumagi T, Guindi M, Fischer SE, Arenovich T, Abdalian R, Coltescu C, Heathcote EJ, Hirschfield GM (2010) Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis. Am J Gastroenterol 105:2186\u20132194","journal-title":"Am J Gastroenterol"},{"key":"4853_CR35","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1007\/s00535-013-0903-1","volume":"49","author":"C Lammert","year":"2014","unstructured":"Lammert C, Juran BD, Schlicht E, Chan LL, Atkinson EJ, de Andrade M, Lazaridis KN (2014) Biochemical response to ursodeoxycholic acid predicts survival in a North American cohort of primary biliary cirrhosis patients. J Gastroenterol 49:1414\u20131420","journal-title":"J Gastroenterol"},{"key":"4853_CR36","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s00535-009-0051-9","volume":"44","author":"N Azemoto","year":"2009","unstructured":"Azemoto N, Abe M, Murata Y, Hiasa Y, Hamada M, Matsuura B, Onji M (2009) Early biochemical response to ursodeoxycholic acid predicts symptom development in patients with asymptomatic primary biliary cirrhosis. J Gastroenterol 44:630\u2013634","journal-title":"J Gastroenterol"},{"key":"4853_CR37","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1872-034X.2011.00782.x","volume":"41","author":"N Azemoto","year":"2011","unstructured":"Azemoto N, Kumagi T, Abe M, Konishi I, Matsuura B, Hiasa Y, Onji M (2011) Biochemical response to ursodeoxycholic acid predicts long-term outcome in Japanese patients with primary biliary cirrhosis. Hepatol Res 41:310\u2013317","journal-title":"Hepatol Res"},{"key":"4853_CR38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11684-007-0012-8","volume":"1","author":"L Li","year":"2007","unstructured":"Li L, Jiang W, Wang J (2007) Clinical analysis of 275 cases of acute drug-induced liver disease. Front Med China 1:58\u201361","journal-title":"Front Med China"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04853-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04853-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04853-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T01:04:25Z","timestamp":1607130265000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04853-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,6]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["4853"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04853-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,6]]},"assertion":[{"value":"27 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of West China Hospital (No. 2016.214). All subjects provided informed consent prior to enrollment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}